Disease-Modifying Therapies for Relapsing–Remitting and Primary Progressive Multiple Sclerosis: A Cost-Utility AnalysisMarita Zimmermann,Elizabeth Brouwer,Jeffrey A. Tice,Matt Seidner,Anne M. Loos,Shanshan Liu,Richard H. Chapman,Varun Kumar,Josh J. CarlsonCNS Drugs（2018）引用 37|浏览21AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
